25 XP   0   0   10

Lionco Pharm Grp Co Ltd
Buy, Hold or Sell?

Let's analyse Lionco Pharm Grp Co Ltd together

PenkeI guess you are interested in Lionco Pharm Grp Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Lionco Pharm Grp Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Lionco Pharm Grp Co Ltd

I send you an email if I find something interesting about Lionco Pharm Grp Co Ltd.

Quick analysis of Lionco Pharm Grp Co Ltd (30 sec.)










What can you expect buying and holding a share of Lionco Pharm Grp Co Ltd? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
91.9%

What is your share worth?

Current worth
¥1.43
Expected worth in 1 year
¥1.08
How sure are you?
75.7%

+ What do you gain per year?

Total Gains per Share
¥-0.35
Return On Investment
-8.6%

For what price can you sell your share?

Current Price per Share
¥4.00
Expected price per share
¥2.94 - ¥4.52
How sure are you?
50%

1. Valuation of Lionco Pharm Grp Co Ltd (5 min.)




Live pricePrice per Share (EOD)

¥4.00

Intrinsic Value Per Share

¥-1.40 - ¥-1.69

Total Value Per Share

¥0.04 - ¥-0.25

2. Growth of Lionco Pharm Grp Co Ltd (5 min.)




Is Lionco Pharm Grp Co Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$143.2m$194.2m-$43.9m-29.2%

How much money is Lionco Pharm Grp Co Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$7.7m-$2.8m-$4.8m-63.0%
Net Profit Margin-138.1%-46.2%--

How much money comes from the company's main activities?

3. Financial Health of Lionco Pharm Grp Co Ltd (5 min.)




What can you expect buying and holding a share of Lionco Pharm Grp Co Ltd? (5 min.)

Welcome investor! Lionco Pharm Grp Co Ltd's management wants to use your money to grow the business. In return you get a share of Lionco Pharm Grp Co Ltd.

What can you expect buying and holding a share of Lionco Pharm Grp Co Ltd?

First you should know what it really means to hold a share of Lionco Pharm Grp Co Ltd. And how you can make/lose money.

Speculation

The Price per Share of Lionco Pharm Grp Co Ltd is ¥4. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Lionco Pharm Grp Co Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Lionco Pharm Grp Co Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥1.43. Based on the TTM, the Book Value Change Per Share is ¥-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is ¥-0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Lionco Pharm Grp Co Ltd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps-0.01-0.1%-0.01-0.3%0.00-0.1%0.000.0%0.000.1%
Usd Book Value Change Per Share-0.01-0.1%-0.01-0.3%-0.01-0.2%0.00-0.1%0.010.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.1%0.010.2%0.010.3%
Usd Total Gains Per Share0.00-0.1%-0.01-0.3%0.00-0.1%0.010.2%0.020.4%
Usd Price Per Share0.71-0.73-1.03-1.09-1.90-
Price to Earnings Ratio-34.64--20.52--1.01-39.79-67.90-
Price-to-Total Gains Ratio-143.38--104.60--189.22-0.96-127.29-
Price to Book Ratio3.60-3.50-3.79-4.23-8.18-
Price-to-Total Gains Ratio-143.38--104.60--189.22-0.96-127.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.5536
Number of shares1806
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.01
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.01
Gains per Quarter (1806 shares)-21.5810.92
Gains per Year (1806 shares)-86.3043.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12-88-9666-2334
23-176-182133-4578
35-264-268199-68122
47-352-354265-91166
59-440-440332-113210
610-528-526398-136254
712-616-612464-158298
814-704-698531-181342
916-792-784597-204386
1017-880-870663-226430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%6.06.00.050.0%14.06.00.070.0%31.06.00.083.8%31.06.00.083.8%
Book Value Change Per Share0.04.00.00.0%4.08.00.033.3%9.011.00.045.0%21.014.02.056.8%21.014.02.056.8%
Dividend per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%34.00.03.091.9%34.00.03.091.9%
Total Gains per Share0.04.00.00.0%5.07.00.041.7%12.08.00.060.0%28.08.01.075.7%28.08.01.075.7%

Fundamentals of Lionco Pharm Grp Co Ltd

About Lionco Pharm Grp Co Ltd

Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.

Fundamental data was last updated by Penke on 2024-03-27 23:26:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Lionco Pharm Grp Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Lionco Pharm Grp Co Ltd earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -71.2% means that ¥-0.71 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -71.2%. The company is making a huge loss. -2
  • The TTM is -138.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-71.2%TTM-138.1%+66.9%
TTM-138.1%YOY-46.2%-91.8%
TTM-138.1%5Y-29.6%-108.5%
5Y-29.6%10Y-5.0%-24.5%
1.1.2. Return on Assets

Shows how efficient Lionco Pharm Grp Co Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -1.5% Return on Assets means that Lionco Pharm Grp Co Ltd generated ¥-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -1.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.5%TTM-3.0%+1.5%
TTM-3.0%YOY-1.1%-1.9%
TTM-3.0%5Y0.2%-3.3%
5Y0.2%10Y1.7%-1.4%
1.1.3. Return on Equity

Shows how efficient Lionco Pharm Grp Co Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.6% Return on Equity means Lionco Pharm Grp Co Ltd generated ¥-0.03 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -2.6%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-5.0%+2.5%
TTM-5.0%YOY-1.6%-3.4%
TTM-5.0%5Y0.3%-5.4%
5Y0.3%10Y2.4%-2.1%

1.2. Operating Efficiency of Lionco Pharm Grp Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Lionco Pharm Grp Co Ltd is operating .

  • Measures how much profit Lionco Pharm Grp Co Ltd makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -6.3% means the company generated ¥-0.06  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is -6.3%. The company is operating very inefficient. -2
  • The TTM is -30.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-30.7%+24.4%
TTM-30.7%YOY-41.8%+11.1%
TTM-30.7%5Y-6.8%-24.0%
5Y-6.8%10Y-3.2%-3.6%
1.2.2. Operating Ratio

Measures how efficient Lionco Pharm Grp Co Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.86 means that the operating costs are ¥1.86 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 1.860. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.673. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.860TTM2.673-0.812
TTM2.673YOY1.788+0.885
TTM2.6735Y1.500+1.173
5Y1.50010Y0.990+0.510

1.3. Liquidity of Lionco Pharm Grp Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Lionco Pharm Grp Co Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 3.24 means the company has ¥3.24 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 3.244. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.414. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.244TTM3.414-0.170
TTM3.414YOY4.016-0.602
TTM3.4145Y3.145+0.269
5Y3.14510Y1.914+1.231
1.3.2. Quick Ratio

Measures if Lionco Pharm Grp Co Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.51 means the company can pay off ¥1.51 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 1.513. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.626. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.513TTM1.626-0.113
TTM1.626YOY1.804-0.178
TTM1.6265Y1.231+0.396
5Y1.23110Y0.876+0.355

1.4. Solvency of Lionco Pharm Grp Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Lionco Pharm Grp Co Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Lionco Pharm Grp Co Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.43 means that Lionco Pharm Grp Co Ltd assets are financed with 42.6% credit (debt) and the remaining percentage (100% - 42.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 0.426. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.410. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.426TTM0.410+0.016
TTM0.410YOY0.373+0.037
TTM0.4105Y0.382+0.028
5Y0.38210Y0.288+0.094
1.4.2. Debt to Equity Ratio

Measures if Lionco Pharm Grp Co Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 74.2% means that company has ¥0.74 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Lionco Pharm Grp Co Ltd:

  • The MRQ is 0.742. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.696. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.742TTM0.696+0.046
TTM0.696YOY0.602+0.094
TTM0.6965Y0.633+0.063
5Y0.63310Y0.447+0.186

2. Market Valuation of Lionco Pharm Grp Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Lionco Pharm Grp Co Ltd generates.

  • Above 15 is considered overpriced but always compare Lionco Pharm Grp Co Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -34.64 means the investor is paying ¥-34.64 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Lionco Pharm Grp Co Ltd:

  • The EOD is -26.851. Based on the earnings, the company is expensive. -2
  • The MRQ is -34.637. Based on the earnings, the company is expensive. -2
  • The TTM is -20.519. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-26.851MRQ-34.637+7.787
MRQ-34.637TTM-20.519-14.119
TTM-20.519YOY-1.005-19.513
TTM-20.5195Y39.792-60.311
5Y39.79210Y67.900-28.108
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Lionco Pharm Grp Co Ltd:

  • The EOD is -6,743.426. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -8,699.019. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2,207.121. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6,743.426MRQ-8,699.019+1,955.593
MRQ-8,699.019TTM-2,207.121-6,491.898
TTM-2,207.121YOY-22.285-2,184.835
TTM-2,207.1215Y-436.101-1,771.020
5Y-436.10110Y-208.647-227.454
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Lionco Pharm Grp Co Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Lionco Pharm Grp Co Ltd:

  • The EOD is 2.788. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.596. Based on the equity, the company is fair priced.
  • The TTM is 3.496. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.788MRQ3.596-0.808
MRQ3.596TTM3.496+0.101
TTM3.496YOY3.786-0.290
TTM3.4965Y4.233-0.737
5Y4.23310Y8.182-3.950
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Lionco Pharm Grp Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.037-0.088+136%-0.063+70%-0.023-39%0.039-196%
Book Value Per Share--1.4351.506-5%1.946-26%1.841-22%1.647-13%
Current Ratio--3.2443.414-5%4.016-19%3.145+3%1.914+69%
Debt To Asset Ratio--0.4260.410+4%0.373+14%0.382+11%0.288+48%
Debt To Equity Ratio--0.7420.696+7%0.602+23%0.633+17%0.447+66%
Dividend Per Share--0.0010.002-28%0.029-96%0.066-98%0.076-98%
Eps---0.037-0.085+130%-0.029-23%0.009-519%0.032-217%
Free Cash Flow Per Share--0.000-0.033+22062%0.016-101%0.007-102%0.025-101%
Free Cash Flow To Equity Per Share---0.001-0.037+2840%-0.277+21829%-0.004+198%0.094-101%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.688--------
Intrinsic Value_10Y_min---1.397--------
Intrinsic Value_1Y_max---0.015--------
Intrinsic Value_1Y_min---0.015--------
Intrinsic Value_3Y_max---0.163--------
Intrinsic Value_3Y_min---0.153--------
Intrinsic Value_5Y_max---0.452--------
Intrinsic Value_5Y_min---0.410--------
Market Cap2884955904.000-29%3721593116.1603799126306.080-2%5349790104.480-30%5670020209.824-34%9894225275.413-62%
Net Profit Margin---0.712-1.381+94%-0.462-35%-0.296-58%-0.050-93%
Operating Margin---0.063-0.307+386%-0.418+561%-0.068+7%-0.032-50%
Operating Ratio--1.8602.673-30%1.788+4%1.500+24%0.990+88%
Pb Ratio2.788-29%3.5963.496+3%3.786-5%4.233-15%8.182-56%
Pe Ratio-26.851+22%-34.637-20.519-41%-1.005-97%39.792-187%67.900-151%
Price Per Share4.000-29%5.1605.268-2%7.418-30%7.862-34%13.718-62%
Price To Free Cash Flow Ratio-6743.426+22%-8699.019-2207.121-75%-22.285-100%-436.101-95%-208.647-98%
Price To Total Gains Ratio-111.147+22%-143.380-104.595-27%-189.223+32%0.958-15067%127.291-213%
Quick Ratio--1.5131.626-7%1.804-16%1.231+23%0.876+73%
Return On Assets---0.015-0.030+103%-0.011-23%0.002-710%0.017-190%
Return On Equity---0.026-0.050+94%-0.016-37%0.003-868%0.024-207%
Total Gains Per Share---0.036-0.086+140%-0.034-5%0.044-182%0.114-131%
Usd Book Value--143218592.233150295132.857-5%194223951.328-26%183755321.298-22%164362715.586-13%
Usd Book Value Change Per Share---0.005-0.012+136%-0.009+70%-0.003-39%0.005-196%
Usd Book Value Per Share--0.1990.208-5%0.269-26%0.255-22%0.228-13%
Usd Dividend Per Share--0.0000.000-28%0.004-96%0.009-98%0.010-98%
Usd Eps---0.005-0.012+130%-0.004-23%0.001-519%0.004-217%
Usd Free Cash Flow---14802.488-3280541.656+22062%1587711.890-101%723023.547-102%2377551.267-101%
Usd Free Cash Flow Per Share--0.000-0.005+22062%0.002-101%0.001-102%0.003-101%
Usd Free Cash Flow To Equity Per Share--0.000-0.005+2840%-0.038+21829%-0.001+198%0.013-101%
Usd Market Cap399277897.114-29%515068487.277525799080.761-2%740410950.460-30%784730797.040-34%1369360778.117-62%
Usd Price Per Share0.554-29%0.7140.729-2%1.027-30%1.088-34%1.899-62%
Usd Profit---3717585.027-7710847.417+107%-2852914.541-23%1050483.014-454%3267122.991-214%
Usd Revenue--5223866.6316529725.342-20%11679698.557-55%29782416.915-82%29325773.771-82%
Usd Total Gains Per Share---0.005-0.012+140%-0.005-5%0.006-182%0.016-131%
 EOD+3 -5MRQTTM+20 -15YOY+10 -255Y+9 -2610Y+6 -29

3.2. Fundamental Score

Let's check the fundamental score of Lionco Pharm Grp Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-26.851
Price to Book Ratio (EOD)Between0-12.788
Net Profit Margin (MRQ)Greater than0-0.712
Operating Margin (MRQ)Greater than0-0.063
Quick Ratio (MRQ)Greater than11.513
Current Ratio (MRQ)Greater than13.244
Debt to Asset Ratio (MRQ)Less than10.426
Debt to Equity Ratio (MRQ)Less than10.742
Return on Equity (MRQ)Greater than0.15-0.026
Return on Assets (MRQ)Greater than0.05-0.015
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Lionco Pharm Grp Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.854
Ma 20Greater thanMa 504.081
Ma 50Greater thanMa 1004.270
Ma 100Greater thanMa 2004.951
OpenGreater thanClose3.910
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets1,803,027
Total Liabilities768,210
Total Stockholder Equity1,034,816
 As reported
Total Liabilities 768,210
Total Stockholder Equity+ 1,034,816
Total Assets = 1,803,027

Assets

Total Assets1,803,027
Total Current Assets1,065,424
Long-term Assets737,603
Total Current Assets
Cash And Cash Equivalents 474,874
Short-term Investments 428,769
Net Receivables 68,187
Inventory 68,505
Other Current Assets 25,088
Total Current Assets  (as reported)1,065,424
Total Current Assets  (calculated)1,065,424
+/- 0
Long-term Assets
Property Plant Equipment 488,336
Intangible Assets 110,591
Other Assets 35,646
Long-term Assets  (as reported)737,603
Long-term Assets  (calculated)634,573
+/- 103,030

Liabilities & Shareholders' Equity

Total Current Liabilities328,466
Long-term Liabilities439,745
Total Stockholder Equity1,034,816
Total Current Liabilities
Short Long Term Debt 217,454
Accounts payable 85,235
Other Current Liabilities 21,763
Total Current Liabilities  (as reported)328,466
Total Current Liabilities  (calculated)324,452
+/- 4,014
Long-term Liabilities
Long term Debt 436,357
Capital Lease Obligations Min Short Term Debt262
Other Liabilities 3,126
Deferred Long Term Liability 17,266
Long-term Liabilities  (as reported)439,745
Long-term Liabilities  (calculated)457,010
+/- 17,266
Total Stockholder Equity
Common Stock721,239
Retained Earnings 23,858
Other Stockholders Equity 94,091
Total Stockholder Equity (as reported)1,034,816
Total Stockholder Equity (calculated)839,188
+/- 195,628
Other
Capital Stock721,239
Common Stock Shares Outstanding 721,239
Net Debt 178,937
Net Invested Capital 1,688,627
Net Tangible Assets 924,225
Net Working Capital 736,958
Property Plant and Equipment Gross 488,336



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-03-31
> Total Assets 
0
559,834
0
1,283,725
1,289,779
1,343,507
1,311,653
1,291,127
1,257,591
1,344,016
1,342,482
1,416,791
1,488,195
1,651,653
1,665,108
1,697,034
1,711,518
2,067,927
2,011,348
1,987,072
2,106,744
1,913,436
2,021,858
1,920,216
2,055,286
2,716,209
2,750,706
2,770,338
2,695,794
2,514,364
2,464,017
2,161,380
1,882,313
1,855,465
1,908,017
1,797,721
1,803,027
1,803,0271,797,7211,908,0171,855,4651,882,3132,161,3802,464,0172,514,3642,695,7942,770,3382,750,7062,716,2092,055,2861,920,2162,021,8581,913,4362,106,7441,987,0722,011,3482,067,9271,711,5181,697,0341,665,1081,651,6531,488,1951,416,7911,342,4821,344,0161,257,5911,291,1271,311,6531,343,5071,289,7791,283,7250559,8340
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,170,595
1,040,479
1,326,462
1,273,420
1,252,768
1,377,557
1,226,063
1,343,328
1,239,870
1,364,301
2,038,816
2,062,371
2,090,513
2,015,644
1,788,287
1,718,080
1,416,520
1,139,604
1,132,043
1,183,110
1,055,323
1,065,424
1,065,4241,055,3231,183,1101,132,0431,139,6041,416,5201,718,0801,788,2872,015,6442,090,5132,062,3712,038,8161,364,3011,239,8701,343,3281,226,0631,377,5571,252,7681,273,4201,326,4621,040,4791,170,595000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
347,123
382,698
711,445
468,370
700,775
546,986
510,986
537,129
813,883
947,277
1,566,976
1,048,474
999,369
979,692
986,937
886,641
686,512
530,691
575,763
504,267
428,603
474,874
474,874428,603504,267575,763530,691686,512886,641986,937979,692999,3691,048,4741,566,976947,277813,883537,129510,986546,986700,775468,370711,445382,698347,123000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
420,000
0
325,000
0
250,000
0
355,776
420,046
101,112
101,112
180,000
710,412
766,225
775,819
579,125
601,156
494,716
405,023
389,515
484,455
479,014
428,769
428,769479,014484,455389,515405,023494,716601,156579,125775,819766,225710,412180,000101,112101,112420,046355,7760250,0000325,0000420,000000000000000000
       Net Receivables 
0
9,807
0
21,125
14,546
76,610
47,260
75,454
53,287
74,240
62,721
111,551
125,135
198,627
164,839
244,982
158,811
183,591
137,986
186,699
200,060
240,712
269,287
184,567
173,609
181,903
190,720
201,335
171,417
132,607
134,602
166,782
130,800
92,215
103,359
71,583
68,187
68,18771,583103,35992,215130,800166,782134,602132,607171,417201,335190,720181,903173,609184,567269,287240,712200,060186,699137,986183,591158,811244,982164,839198,627125,135111,55162,72174,24053,28775,45447,26076,61014,54621,12509,8070
       Other Current Assets 
0
13,858
0
16,426
622,623
22,340
562,265
15,592
486,687
18,386
521,309
24,592
542,034
29,171
542,034
81,790
434,271
37,124
555,581
266,527
539,394
28,783
25,525
32,413
44,625
40,872
34,484
48,015
31,381
37,951
47,110
24,657
27,701
13,557
13,399
27,077
25,088
25,08827,07713,39913,55727,70124,65747,11037,95131,38148,01534,48440,87244,62532,41325,52528,783539,394266,527555,58137,124434,27181,790542,03429,171542,03424,592521,30918,386486,68715,592562,26522,340622,62316,426013,8580
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
737,928
734,304
729,186
687,372
678,530
680,345
690,985
677,392
688,335
679,825
680,150
726,077
745,937
744,860
742,708
723,422
724,907
742,398
737,603
737,603742,398724,907723,422742,708744,860745,937726,077680,150679,825688,335677,392690,985680,345678,530687,372729,186734,304737,928000000000000000000
       Property Plant Equipment 
0
306,124
0
321,439
320,950
329,765
333,387
318,731
318,512
333,058
329,060
348,415
342,954
405,402
405,462
413,926
434,185
490,822
489,024
485,115
484,740
490,518
482,203
490,460
486,322
465,468
478,405
471,868
471,723
484,532
483,977
474,521
476,643
496,324
493,771
489,476
488,336
488,336489,476493,771496,324476,643474,521483,977484,532471,723471,868478,405465,468486,322490,460482,203490,518484,740485,115489,024490,822434,185413,926405,462405,402342,954348,415329,060333,058318,512318,731333,387329,765320,950321,4390306,1240
       Goodwill 
0
2,030
0
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
2,030
0
0
0
0
00002,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,0302,03002,0300
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,989
92,225
91,516
90,163
88,354
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000088,35490,16391,51692,22598,9890000000000000000
       Intangible Assets 
0
49,047
0
48,671
48,419
48,183
47,932
47,680
47,740
47,480
47,220
46,960
46,700
46,440
46,188
44,379
47,735
47,522
47,288
1,027
46,678
50,498
50,091
50,099
104,137
102,698
102,022
101,324
100,637
124,097
122,923
122,705
121,885
115,791
114,002
112,286
110,591
110,591112,286114,002115,791121,885122,705122,923124,097100,637101,324102,022102,698104,13750,09950,09150,49846,6781,02747,28847,52247,73544,37946,18846,44046,70046,96047,22047,48047,74047,68047,93248,18348,41948,671049,0470
       Other Assets 
0
69,439
0
65,869
65,099
69,363
64,563
76,682
76,077
117,860
124,110
126,229
134,327
114,099
111,723
66,105
88,101
108,866
108,069
110,013
107,384
62,636
64,245
59,135
20,691
44,146
43,959
44,088
44,069
48,751
41,132
49,957
46,630
33,509
0
36,304
35,646
35,64636,304033,50946,63049,95741,13248,75144,06944,08843,95944,14620,69159,13564,24562,636107,384110,013108,069108,86688,10166,105111,723114,099134,327126,229124,110117,86076,07776,68264,56369,36365,09965,869069,4390
> Total Liabilities 
0
185,703
0
242,514
219,937
223,982
165,794
202,376
140,739
174,566
144,777
219,574
253,175
352,398
333,206
432,615
350,124
689,968
597,248
663,414
843,788
599,604
642,016
632,012
691,014
1,236,334
1,235,725
1,364,348
1,224,423
1,055,533
993,938
765,718
593,474
720,321
795,864
736,044
768,210
768,210736,044795,864720,321593,474765,718993,9381,055,5331,224,4231,364,3481,235,7251,236,334691,014632,012642,016599,604843,788663,414597,248689,968350,124432,615333,206352,398253,175219,574144,777174,566140,739202,376165,794223,982219,937242,5140185,7030
   > Total Current Liabilities 
0
167,791
0
225,374
203,183
207,090
149,288
186,374
125,182
160,732
131,416
206,765
240,837
340,055
221,320
321,186
244,072
504,372
412,110
479,135
659,933
400,705
443,480
433,905
393,338
731,573
713,340
927,402
835,228
648,849
575,764
358,002
179,024
302,423
370,546
303,727
328,466
328,466303,727370,546302,423179,024358,002575,764648,849835,228927,402713,340731,573393,338433,905443,480400,705659,933479,135412,110504,372244,072321,186221,320340,055240,837206,765131,416160,732125,182186,374149,288207,090203,183225,3740167,7910
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
200,000
200,000
260,000
60,043
160,097
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000160,09760,043260,000200,000200,00020,00000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,000
200,000
200,000
260,000
60,043
160,097
266,349
283,772
389,746
370,401
513,754
565,842
460,291
400,262
202,960
103,849
205,243
255,237
217,095
217,454
217,454217,095255,237205,243103,849202,960400,262460,291565,842513,754370,401389,746283,772266,349160,09760,043260,000200,000200,00020,00000000000000000000
       Accounts payable 
0
126,709
0
108,750
101,234
94,398
116,947
92,551
96,214
87,536
92,826
118,921
138,389
96,468
82,154
84,918
104,249
105,415
149,794
147,256
145,627
109,023
138,142
76,763
52,426
39,023
88,988
85,675
58,574
62,102
56,434
49,280
50,046
66,455
72,291
57,598
85,235
85,23557,59872,29166,45550,04649,28056,43462,10258,57485,67588,98839,02352,42676,763138,142109,023145,627147,256149,794105,415104,24984,91882,15496,468138,389118,92192,82687,53696,21492,551116,94794,398101,234108,7500126,7090
       Other Current Liabilities 
0
41,081
0
36,623
31,949
62,692
32,340
43,823
28,967
73,195
38,589
87,844
102,447
243,587
139,166
36,323
135,034
71,217
16,003
15,860
1,063
55,552
138,479
44,144
52,922
47,189
60,021
30,701
37,225
26,808
28,914
99,828
18,529
21,021
1,750
21,728
21,763
21,76321,7281,75021,02118,52999,82828,91426,80837,22530,70160,02147,18952,92244,144138,47955,5521,06315,86016,00371,217135,03436,323139,166243,587102,44787,84438,58973,19528,96743,82332,34062,69231,94936,623041,0810
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
185,139
184,279
183,855
198,900
198,536
198,106
297,677
504,760
522,385
436,946
389,196
406,684
418,174
407,716
414,451
417,898
425,318
432,317
439,745
439,745432,317425,318417,898414,451407,716418,174406,684389,196436,946522,385504,760297,677198,106198,536198,900183,855184,279185,139000000000000000000
       Other Liabilities 
0
17,912
0
17,140
16,754
16,892
16,506
16,002
15,557
13,834
13,361
12,809
12,338
12,343
11,886
11,429
11,052
10,595
10,139
9,279
8,855
8,900
8,536
8,106
7,677
7,221
6,792
6,363
5,934
6,004
5,514
5,319
4,839
0
0
3,385
3,126
3,1263,385004,8395,3195,5146,0045,9346,3636,7927,2217,6778,1068,5368,9008,8559,27910,13910,59511,05211,42911,88612,34312,33812,80913,36113,83415,55716,00216,50616,89216,75417,140017,9120
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,023
16,235
17,376
17,029
17,060
15,564
14,566
13,020
11,474
11,256
26,501
26,059
25,191
24,934
23,917
22,769
22,234
21,099
20,096
0
18,145
17,266
17,26618,145020,09621,09922,23422,76923,91724,93425,19126,05926,50111,25611,47413,02014,56615,56417,06017,02917,37616,23516,023000000000000000
> Total Stockholder Equity
351,023
374,131
374,131
1,041,211
1,069,842
1,119,525
1,145,860
1,088,751
1,116,852
1,169,450
1,197,705
1,197,217
1,235,020
1,299,255
1,331,902
1,264,420
1,361,394
1,377,959
1,414,100
1,323,658
1,262,955
1,313,832
1,379,842
1,288,204
1,364,271
1,479,875
1,514,981
1,405,990
1,471,371
1,458,831
1,470,079
1,395,662
1,288,838
1,135,144
1,112,152
1,061,678
1,034,816
1,034,8161,061,6781,112,1521,135,1441,288,8381,395,6621,470,0791,458,8311,471,3711,405,9901,514,9811,479,8751,364,2711,288,2041,379,8421,313,8321,262,9551,323,6581,414,1001,377,9591,361,3941,264,4201,331,9021,299,2551,235,0201,197,2171,197,7051,169,4501,116,8521,088,7511,145,8601,119,5251,069,8421,041,211374,131374,131351,023
   Common Stock
0
195,000
0
260,000
260,000
260,000
260,000
260,000
260,000
260,000
260,000
260,000
260,000
260,000
260,000
364,000
364,000
364,000
364,000
509,600
509,600
509,600
509,600
713,440
713,440
713,440
713,440
713,443
721,167
721,227
721,228
721,228
721,228
721,238
0
721,239
721,239
721,239721,2390721,238721,228721,228721,228721,227721,167713,443713,440713,440713,440713,440509,600509,600509,600509,600364,000364,000364,000364,000260,000260,000260,000260,000260,000260,000260,000260,000260,000260,000260,000260,0000195,0000
   Retained Earnings Total Equity0000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0000000000000000000000000000000000000
   Capital Surplus 0000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
107,890
107,890
107,885
94,218
94,111
94,110
94,110
94,109
94,092
0
94,091
94,091
94,09194,091094,09294,10994,11094,11094,11194,218107,885107,890107,8900000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue188,720
Cost of Revenue-113,705
Gross Profit75,01675,016
 
Operating Income (+$)
Gross Profit75,016
Operating Expense-354,891
Operating Income-166,170-279,875
 
Operating Expense (+$)
Research Development34,993
Selling General Administrative160,394
Selling And Marketing Expenses-
Operating Expense354,891195,387
 
Net Interest Income (+$)
Interest Income10,395
Interest Expense-2,763
Other Finance Cost-6,716
Net Interest Income916
 
Pretax Income (+$)
Operating Income-166,170
Net Interest Income916
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-216,821-166,170
EBIT - interestExpense = -2,763
-222,857
-220,094
Interest Expense2,763
Earnings Before Interest and Taxes (EBIT)--214,057
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-216,821
Tax Provision-6,036
Net Income From Continuing Ops-222,857-222,857
Net Income-222,857
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--916
 

Technical Analysis of Lionco Pharm Grp Co Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Lionco Pharm Grp Co Ltd. The general trend of Lionco Pharm Grp Co Ltd is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Lionco Pharm Grp Co Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Lionco Pharm Grp Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.4 < 4.45 < 4.52.

The bearish price targets are: 3.77 > 2.94.

Tweet this
Lionco Pharm Grp Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Lionco Pharm Grp Co Ltd. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Lionco Pharm Grp Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Lionco Pharm Grp Co Ltd. The current macd is -0.03079742.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lionco Pharm Grp Co Ltd price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Lionco Pharm Grp Co Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Lionco Pharm Grp Co Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Lionco Pharm Grp Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartLionco Pharm Grp Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Lionco Pharm Grp Co Ltd. The current adx is 21.97.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Lionco Pharm Grp Co Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Lionco Pharm Grp Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Lionco Pharm Grp Co Ltd. The current sar is 4.418416.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Lionco Pharm Grp Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Lionco Pharm Grp Co Ltd. The current rsi is 45.85. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Lionco Pharm Grp Co Ltd Daily Relative Strength Index (RSI) ChartLionco Pharm Grp Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Lionco Pharm Grp Co Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Lionco Pharm Grp Co Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Lionco Pharm Grp Co Ltd Daily Stochastic Oscillator ChartLionco Pharm Grp Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Lionco Pharm Grp Co Ltd. The current cci is -57.57185757.

Lionco Pharm Grp Co Ltd Daily Commodity Channel Index (CCI) ChartLionco Pharm Grp Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Lionco Pharm Grp Co Ltd. The current cmo is -9.88913332.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Lionco Pharm Grp Co Ltd Daily Chande Momentum Oscillator (CMO) ChartLionco Pharm Grp Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Lionco Pharm Grp Co Ltd. The current willr is -66.17647059.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Lionco Pharm Grp Co Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Lionco Pharm Grp Co Ltd Daily Williams %R ChartLionco Pharm Grp Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Lionco Pharm Grp Co Ltd.

Lionco Pharm Grp Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Lionco Pharm Grp Co Ltd. The current atr is 0.23513857.

Lionco Pharm Grp Co Ltd Daily Average True Range (ATR) ChartLionco Pharm Grp Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Lionco Pharm Grp Co Ltd. The current obv is 82,051,445.

Lionco Pharm Grp Co Ltd Daily On-Balance Volume (OBV) ChartLionco Pharm Grp Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Lionco Pharm Grp Co Ltd. The current mfi is 54.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Lionco Pharm Grp Co Ltd Daily Money Flow Index (MFI) ChartLionco Pharm Grp Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Lionco Pharm Grp Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-09MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-28ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Lionco Pharm Grp Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Lionco Pharm Grp Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5045.854
Ma 20Greater thanMa 504.081
Ma 50Greater thanMa 1004.270
Ma 100Greater thanMa 2004.951
OpenGreater thanClose3.910
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Lionco Pharm Grp Co Ltd with someone you think should read this too:
  • Are you bullish or bearish on Lionco Pharm Grp Co Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Lionco Pharm Grp Co Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Lionco Pharm Grp Co Ltd

I send you an email if I find something interesting about Lionco Pharm Grp Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Lionco Pharm Grp Co Ltd.

Receive notifications about Lionco Pharm Grp Co Ltd in your mailbox!